As of March 2026 Lyell Immunopharma has a market cap of NZ$0.79 Billion. This makes Lyell Immunopharma the world's 7261th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 28th, 2026 the market cap of Lyell Immunopharma was reported to be: